Annual Revenue
$1.78 M
+$274.60 K+18.24%
December 31, 2023
Summary
- As of February 7, 2025, POAI annual revenue is $1.78 million, with the most recent change of +$274.60 thousand (+18.24%) on December 31, 2023.
- During the last 3 years, POAI annual revenue has risen by +$527.80 thousand (+42.15%).
- POAI annual revenue is now at all-time high.
Performance
POAI Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$345.70 K
+$67.00 K+24.04%
September 30, 2024
Summary
- As of February 7, 2025, POAI quarterly revenue is $345.70 thousand, with the most recent change of +$67.00 thousand (+24.04%) on September 30, 2024.
- Over the past year, POAI quarterly revenue has increased by +$67.00 thousand (+24.04%).
- POAI quarterly revenue is now -48.91% below its all-time high of $676.60 thousand, reached on September 30, 2023.
Performance
POAI Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$1.52 M
-$330.90 K-17.92%
September 30, 2024
Summary
- As of February 7, 2025, POAI TTM revenue is $1.52 million, with the most recent change of -$330.90 thousand (-17.92%) on September 30, 2024.
- Over the past year, POAI TTM revenue has dropped by -$330.90 thousand (-17.92%).
- POAI TTM revenue is now -26.35% below its all-time high of $2.06 million, reached on March 31, 2024.
Performance
POAI TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
POAI Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.2% | +24.0% | -17.9% |
| 3 y3 years | +42.1% | -29.5% | -2.1% |
| 5 y5 years | +26.1% | -29.5% | -2.1% |
POAI Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +25.3% | -48.9% | +44.1% | -26.4% | +6.7% |
| 5 y | 5-year | at high | +42.1% | -48.9% | +89.1% | -26.4% | +22.5% |
| alltime | all time | at high | >+9999.0% | -48.9% | >+9999.0% | -26.4% | >+9999.0% |
Predictive Oncology Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $345.70 K(+24.0%) | $1.52 M(-17.9%) |
| Jun 2024 | - | $278.70 K(-33.6%) | $1.85 M(-10.3%) |
| Mar 2024 | - | $419.60 K(-11.1%) | $2.06 M(+9.6%) |
| Dec 2023 | $1.78 M(+18.2%) | $472.00 K(-30.2%) | $1.88 M(+6.1%) |
| Sep 2023 | - | $676.60 K(+38.1%) | $1.77 M(+14.3%) |
| Jun 2023 | - | $490.10 K(+104.3%) | $1.55 M(+8.3%) |
| Mar 2023 | - | $239.90 K(-34.0%) | $1.43 M(-5.0%) |
| Dec 2022 | $1.51 M(+6.0%) | $363.50 K(-20.3%) | $1.51 M(-7.0%) |
| Sep 2022 | - | $455.80 K(+22.7%) | $1.62 M(+9.6%) |
| Jun 2022 | - | $371.60 K(+18.1%) | $1.48 M(+1.5%) |
| Mar 2022 | - | $314.60 K(-34.0%) | $1.46 M(+2.4%) |
| Dec 2021 | $1.42 M(+13.4%) | $476.50 K(+51.9%) | $1.42 M(+14.8%) |
| Sep 2021 | - | $313.70 K(-10.4%) | $1.24 M(-11.9%) |
| Jun 2021 | - | $350.20 K(+24.9%) | $1.41 M(+13.5%) |
| Mar 2021 | - | $280.30 K(-4.6%) | $1.24 M(-1.2%) |
| Dec 2020 | $1.25 M(-11.3%) | $293.80 K(-38.9%) | $1.25 M(-4.1%) |
| Sep 2020 | - | $480.80 K(+163.0%) | $1.31 M(-3.1%) |
| Jun 2020 | - | $182.80 K(-38.0%) | $1.35 M(-7.1%) |
| Mar 2020 | - | $294.90 K(-15.1%) | $1.45 M(+2.8%) |
| Dec 2019 | $1.41 M(-0.0%) | $347.50 K(-33.5%) | $1.41 M(+2.6%) |
| Sep 2019 | - | $522.70 K(+82.6%) | $1.38 M(+16.3%) |
| Jun 2019 | - | $286.20 K(+12.1%) | $1.18 M(-5.8%) |
| Mar 2019 | - | $255.20 K(-18.1%) | $1.26 M(-11.1%) |
| Dec 2018 | $1.41 M(+115.6%) | $311.50 K(-5.6%) | $1.41 M(+6.9%) |
| Sep 2018 | - | $329.90 K(-8.0%) | $1.32 M(+15.5%) |
| Jun 2018 | - | $358.60 K(-12.9%) | $1.14 M(+28.3%) |
| Mar 2018 | - | $411.60 K(+86.8%) | $891.20 K(+36.1%) |
| Dec 2017 | $654.80 K | $220.30 K(+44.5%) | $654.80 K(+14.1%) |
| Sep 2017 | - | $152.50 K(+42.8%) | $574.10 K(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | $106.80 K(-39.0%) | $556.20 K(+4.0%) |
| Mar 2017 | - | $175.20 K(+25.5%) | $534.80 K(+17.2%) |
| Dec 2016 | $456.50 K(-30.2%) | $139.60 K(+3.7%) | $456.50 K(-8.7%) |
| Sep 2016 | - | $134.60 K(+57.6%) | $500.20 K(+10.8%) |
| Jun 2016 | - | $85.40 K(-11.9%) | $451.40 K(-24.8%) |
| Mar 2016 | - | $96.90 K(-47.1%) | $600.00 K(-8.3%) |
| Dec 2015 | $654.40 K(-31.2%) | $183.30 K(+113.6%) | $654.40 K(+2.7%) |
| Sep 2015 | - | $85.80 K(-63.3%) | $636.90 K(-32.8%) |
| Jun 2015 | - | $234.00 K(+54.7%) | $948.40 K(-8.2%) |
| Mar 2015 | - | $151.30 K(-8.7%) | $1.03 M(+8.5%) |
| Dec 2014 | $951.60 K(+103.3%) | $165.80 K(-58.3%) | $951.60 K(+9.7%) |
| Sep 2014 | - | $397.30 K(+24.8%) | $867.50 K(+50.1%) |
| Jun 2014 | - | $318.30 K(+353.4%) | $578.00 K(+40.8%) |
| Mar 2014 | - | $70.20 K(-14.1%) | $410.60 K(-12.3%) |
| Dec 2013 | $468.10 K(+147.9%) | $81.70 K(-24.2%) | $468.10 K(-1.7%) |
| Sep 2013 | - | $107.80 K(-28.6%) | $476.00 K(+13.4%) |
| Jun 2013 | - | $150.90 K(+18.2%) | $419.80 K(+42.8%) |
| Mar 2013 | - | $127.70 K(+42.5%) | $293.90 K(+55.7%) |
| Dec 2012 | $188.80 K(+95.4%) | $89.60 K(+73.6%) | $188.80 K(+9.0%) |
| Sep 2012 | - | $51.60 K(+106.4%) | $173.20 K(+22.1%) |
| Jun 2012 | - | $25.00 K(+10.6%) | $141.90 K(+18.9%) |
| Mar 2012 | - | $22.60 K(-69.5%) | $119.30 K(+23.4%) |
| Dec 2011 | $96.60 K(>+9900.0%) | $74.00 K(+264.5%) | $96.70 K(+326.0%) |
| Sep 2011 | - | $20.30 K(+745.8%) | $22.70 K(+845.8%) |
| Jun 2011 | - | $2400.00(+700.0%) | $2400.00(-85.0%) |
| Dec 2010 | $300.00(-98.1%) | - | - |
| Mar 2010 | - | $300.00(-98.1%) | $16.00 K(+1.9%) |
| Dec 2009 | $15.70 K | - | - |
| Jun 2009 | - | $15.70 K | $15.70 K |
FAQ
- What is Predictive Oncology annual revenue?
- What is the all time high annual revenue for Predictive Oncology?
- What is Predictive Oncology annual revenue year-on-year change?
- What is Predictive Oncology quarterly revenue?
- What is the all time high quarterly revenue for Predictive Oncology?
- What is Predictive Oncology quarterly revenue year-on-year change?
- What is Predictive Oncology TTM revenue?
- What is the all time high TTM revenue for Predictive Oncology?
- What is Predictive Oncology TTM revenue year-on-year change?
What is Predictive Oncology annual revenue?
The current annual revenue of POAI is $1.78 M
What is the all time high annual revenue for Predictive Oncology?
Predictive Oncology all-time high annual revenue is $1.78 M
What is Predictive Oncology annual revenue year-on-year change?
Over the past year, POAI annual revenue has changed by +$274.60 K (+18.24%)
What is Predictive Oncology quarterly revenue?
The current quarterly revenue of POAI is $345.70 K
What is the all time high quarterly revenue for Predictive Oncology?
Predictive Oncology all-time high quarterly revenue is $676.60 K
What is Predictive Oncology quarterly revenue year-on-year change?
Over the past year, POAI quarterly revenue has changed by +$67.00 K (+24.04%)
What is Predictive Oncology TTM revenue?
The current TTM revenue of POAI is $1.52 M
What is the all time high TTM revenue for Predictive Oncology?
Predictive Oncology all-time high TTM revenue is $2.06 M
What is Predictive Oncology TTM revenue year-on-year change?
Over the past year, POAI TTM revenue has changed by -$330.90 K (-17.92%)